TAFAZZIN tafazzin, phospholipid-lysophospholipid transacylase
Information
- Symbol
- TAFAZZIN
- Type
- protein-coding
- Description
- tafazzin, phospholipid-lysophospholipid transacylase
- Entrez Gene ID
- 6901
- Genome
- hg19
- Position
- chrX:153,640,181-153,649,343
- Genome
- hg38
- Position
- chrX:154,411,844-154,421,004
- MIM
- 300394 OMIM
- HGNC
- HGNC:11577 HGNC
- Ensembl
- ENSG00000102125 Ensembl
- Links
- NCBI Gene Cards OncoKB
Clinical Significance
| MGeND | ClinVar | |
|---|---|---|
| Pathogenic | 31 | 108 |
| Likely pathogenic | 12 | 102 |
| Benign | 0 | 34 |
| Likely benign | 0 | 344 |
| Conflicting classifications of pathogenicity | 0 | 51 |
| not provided | 6 | 0 |
| Uncertain significance | 0 | 322 |
Ranking
| ClinVar | |
|---|---|
![]() |
0 |
![]() |
0 |
![]() |
162 |
![]() |
684 |
![]() |
24 |
Frequency
EXAC_EAS
EXAC_EAS
HGVD
HGVD
TOMMO
TOMMO
Gene
Position
EXAC_EAS
EXAC_EAS
HGVD
HGVD
TOMMO
TOMMO
Gene
Position
Disease area statistics
Locus Zoom
Variants
Search Word
| Target data | : |
MGeND data only
|
| Category | : |
|
| Search word | : | |
| Filtering | : |
| Variant name | Gene | AA change | CDS | Japanese frequency |
TogoVar | MGeND | Genome | ClinVar | CIViC evidence | DisGeNET entry | COSMIC occurrence |
Prediction | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Entry | Origin | Type | Annotation | Entry | Origin | Annotation | |||||||||||
Search Word
| Target data | : |
MGeND data only
|
| Category | : |
|
| Search word | : | |
| Filtering | : |
| Name | MGeND | Type | Genome | Size | Chromosome | Start | Stop | Ref | Alt | ClinVar | Origin | Entry | CIViC evidence | DisGeNET entry | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Entry | Origin | Type | Annotation | ||||||||||||||
Search Word
| Target data | : |
MGeND data only
|
| Category | : |
|
| Search word | : | |
| Filtering | : |
| Name | MGeND | Type | Genome | Gene symbol | Chromosome | Genomic start | Genomic stop | Strand | Ref | Alt | ClinVar | Origin | Entry | CIViC evidence | DisGeNET entry | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Entry | Origin | Type | Annotation | |||||||||||||||
| Type | ID |
|---|---|
| SYNONYM | BTHS |
| SYNONYM | CMD3A |
| SYNONYM | EFE |
| SYNONYM | EFE2 |
| SYNONYM | G4.5 |
| SYNONYM | LVNCX |
| SYNONYM | TAZ |
| SYNONYM | Taz1 |
| MIM | 300394 OMIM |
| HGNC | HGNC:11577 HGNC |
| Ensembl | ENSG00000102125 Ensembl |
| AllianceGenome | HGNC:11577 |
| Descrption | Source | Links |
|---|
| ID | Genome | Chromosome | Start | End | Length |
|---|---|---|---|---|---|
| ENST00000613002.4 | hg38 | chrX | 154,411,541 | 154,421,439 | 9,899 |
| ENST00000652358.1 | hg38 | chrX | 154,411,898 | 154,421,053 | 9,156 |
| ENST00000601016.6 | hg38 | chrX | 154,411,539 | 154,421,726 | 10,188 |
| ENST00000652354.1 | hg38 | chrX | 154,412,718 | 154,421,726 | 9,009 |
| ENST00000475699.6 | hg38 | chrX | 154,411,553 | 154,421,502 | 9,950 |
| ENST00000612460.5 | hg38 | chrX | 154,411,539 | 154,421,700 | 10,162 |
| ENST00000651139.1 | hg38 | chrX | 154,420,325 | 154,421,726 | 1,402 |
| ENST00000369776.8 | hg38 | chrX | 154,411,759 | 154,421,726 | 9,968 |
| ENST00000616020.5 | hg38 | chrX | 154,411,844 | 154,421,004 | 9,161 |
| ENST00000612012.5 | hg38 | chrX | 154,411,650 | 154,421,203 | 9,554 |
| ENST00000369776.8 | hg19 | chrX | 153,640,096 | 153,650,065 | 9,970 |
| ENST00000475699.6 | hg19 | chrX | 153,639,889 | 153,649,841 | 9,953 |
| ENST00000612012.5 | hg19 | chrX | 153,639,986 | 153,649,542 | 9,557 |
| ENST00000612460.5 | hg19 | chrX | 153,639,875 | 153,650,039 | 10,165 |
| ENST00000616020.5 | hg19 | chrX | 153,640,181 | 153,649,343 | 9,163 |
| ENST00000601016.6 | hg19 | chrX | 153,639,875 | 153,650,065 | 10,191 |
| ENST00000613002.4 | hg19 | chrX | 153,639,877 | 153,649,778 | 9,902 |
| ENST00000651139.1 | hg19 | chrX | 153,648,664 | 153,650,065 | 1,402 |
| ENST00000652354.1 | hg19 | chrX | 153,641,055 | 153,650,065 | 9,011 |
| ENST00000652358.1 | hg19 | chrX | 153,640,235 | 153,649,392 | 9,158 |
Genome browser




